BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 23 filers reported holding BENITEC BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,833 | +13.6% | 74,773 | 0.0% | 0.00% | – |
| Q1 2023 | $15,695 | +23.5% | 74,773 | 0.0% | 0.00% | – |
| Q4 2022 | $12,711 | -54.6% | 74,773 | 0.0% | 0.00% | – |
| Q3 2022 | $28,000 | -69.2% | 74,773 | -4.6% | 0.00% | – |
| Q2 2022 | $91,000 | -50.3% | 78,371 | 0.0% | 0.00% | – |
| Q1 2022 | $183,000 | -10.7% | 78,371 | 0.0% | 0.00% | – |
| Q4 2021 | $205,000 | -26.8% | 78,371 | 0.0% | 0.00% | – |
| Q3 2021 | $280,000 | -11.9% | 78,371 | +4.8% | 0.00% | – |
| Q2 2021 | $318,000 | +17.8% | 74,773 | +43.3% | 0.00% | – |
| Q1 2021 | $270,000 | – | 52,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 769,000 | $1,796,000 | 0.06% |
| Atom Investors LP | 37,335 | $87,000 | 0.04% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 492,880 | $57,000 | 0.02% |
| WealthTrust Axiom LLC | 12,950 | $30,000 | 0.01% |
| UBS Group AG | 347 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 43 | $0 | 0.00% |
| NORTHERN TRUST CORP | 11,813 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,000 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 59,566 | $139,000 | 0.00% |